Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma

Jhe-Cyuan Guo,Chia-Chi Lin,Chia-Lang Hsu,Ta-Chen Huang,Hung-Yang Kuo,Chen-Yuan Lin,Ming-Yu Lien,Ann-Lii Cheng,Chih-Hung Hsu

DOI: https://doi.org/10.1007/s10388-022-00940-7

2022-07-13

Esophagus

Abstract:Although DNA damage response and repair (DDR) gene alteration has been demonstrated as a biomarker for anti-PD-1 therapy in several cancer types, its role in esophageal squamous cell carcinoma (ESCC) is unknown.

gastroenterology & hepatology